Lugano, Switzerland, 20 April 2022 – The ESMO Breast Cancer Congress 2022 , the annual event dedicated to advancing the science, disseminating education and improving the practice of breast cancer specialists worldwide, will focus this year on integrating translational research for innovative clinical practice.
The event will be held onsite in Berlin, Germany, and online, through a virtual platform, between 3-5 May 2022.
Programme highlights
Keynote lectures
The results of more than 200 studies from various parts of the world will be presented either as oral, mini oral or poster presentations, and published online as a supplement of Annals of Oncology . The abstract titles can be viewed through the online programme.
Media registration
ESMO welcomes media interested in obtaining information and reporting on cancer issues. Only through the official accreditation process with the media registration form , accredited media representatives will be able to access scientific and educational sessions, e-posters, virtual exhibition and industry satellite symposia, Congress webcasts, as well as embargoed material.
Further information
ESMO Press Office
press@esmo.org
-END-
Notes to Editors
Please make sure to use the official name of the meeting in your reports: ESMO Breast Cancer 2022
and the official congress hashtag: #ESMOBreast22
Follow the conversation on Twitter , LinkedIn and watch video material on YouTube
About the European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. Visit www.esmo.org